Erynn S. Gordon, MS, CGC is the Director of Genetic Counseling at the Coriell Institute,
focused on the Coriell Personalized Medicine Collaborative (CPMC™). The Coriell Personalized
Medicine Collaborative™ (CPMC™) is a longitudinal research study that aims to evaluate the
utility of using the knowledge of genetics in medicine when implemented in an ethical, legal
and responsible format. It is a multi-party effort involving study participants, medical
professionals, scientists, ethicists and information technology experts. As a member of the
CPMC™ team, Ms. Gordon is responsible for creating public and healthcare provider educational
pages, providing genetic counseling services to CPMC participants, and conducting research on
the psychosocial and behavioral impact of personalized medicine.
Ms. Gordon received her M.S. in genetic counseling from the University of Pittsburgh School of Public Health in 2001 and joined the Research Center for Genetic Medicine at Children’s
National Medical Center in Washington, DC where she conducted research on the impact of non-
disease genetic testing on self-concept and provided genetic counseling to patients in the
Muscular Dystrophy Association clinic and the neurogenetics clinic. In 2006 Ms. Gordon moved
to the University of Medicine School of Medicine where she was involved in research studies on Huntington’s disease and Tay Sachs disease and where she provided genetic counseling services to the hereditary cancer clinic, the Huntington’s disease clinic and the adult genetics clinic. Ms. Gordon joined the Coriell Institute in the summer of 2008.
Ms. Gordon is an active member of the National Society of Genetic Counselors and has served in numerous leadership positions within the genetic counseling community having served as the
chair of the Ethics Subcommittee of the National Society of Genetic Counselors from 2004-2005, and most recently serving on the Board of Directors for the American Board of Genetic Counseling and the Governor’s Advisory Council on Genetic Counseling for the State of New Jersey.
Publications
Keller MA, Gordon ES, Stack CB, Gharani N, Sill CJ, Schmidlen TJ, Mintzer J, Pallies J,
Gerry NP, Christman MF. The Coriell Personalized Medicine Collaborative (CPMC): A prospective study of the utility of personalized medicine. Personalized Medicine. Invited Special Report – in press.
Gordon E (2009). What PAs should know before they refer patients to a genetic counselor. Journal of the American Academy of Physician Assistants 22(9): 61-62.
PMID: 19827402 abstract
Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR,
Singhal BS, Harding C, Amartino H, Brown CM, Chan A, Renaud D, Geraght M, Jensen L, Senbil N,
Kadom N, Nazarian J, Yuanjian F, Wang Z, Hartka T, Morizono H, Vanderver A (2008). Genetic and clinical heterogeneity in eIF2B-related disorder. Journal of Child
Neurology 23(2):205-15.
PMID: 18263758 abstract
Kesari A, Pirra LN, Bremadesam L, McIntyre O, Gordon E, Dubrovsky AL,Viswanathan V,
Hoffman EP (2008). Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule. Hum Mutat. 29(5):728-37.
PMID: 18348289 abstract
Vanderver A, Hathout Y, Maletkovic J, Gordon ES, Mintz M, Timmons M, Hoffman EP, Horzinski
L, Niel F, Fogli A, Boespflug-Tanguy O, Schiffmann R (2008). A Clinical Biomarker for eIF2B-related disorder: Decreased Cerebrospinal Fluid Asialotransferrin to Transferrin Ratio. Neurology; 70(23):2226-32
PMID: 18519871 abstract
Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P, Sartorelli V, Seo J, Pegoraro E,
Angelini C, Shneiderman B, Escolar D, Chen YW, Winokur ST, Pachman LM, Fan C, Mandler R, Nevo
Y, Gordon E, Zhu Y, Dong Y, Wang Y, Hoffman EP (2006).
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of
Rb-MyoD pathways in muscle regeneration. Brain; 129(Pt 4):996-1013.
PMID: 16478798 abstract
National Society of Genetic Counselors, Code of Ethics Work Group: Bennett RL, Callanan N,
Gordon E, Karns L, Mooney KH, Ruzicka R, Schmerler S, Weissman S (2006). Code of Ethics of the National Society of Genetic Counselors: Explication of Revisions.
Journal of Genetic Counseling; 15(5): 313-323.
PMID: 11651281 abstract
ES Gordon, HA Gordish-Dressman, J Devaney, P Clarkson, P Thompson, P Gordon, LS Pescatello, MJ Hubal, EE Pistilli, G Gianetti, B Kelsey and EP Hoffman (2005). Nondisease genetic testing: reporting of muscle SNPs shows effects on self-concept and
health orientation scales. European Journal of Human Genetics; 37(10):2064-74.
PMID: 15944650 abstract
Wu FF, Gordon ES, Hoffman EP, Cannon SC (2005). A C-terminal skeletal muscle sodium channel mutation associated with myotonia disrupts
fast inactivation. Journal of Physiology; 565(Pt 2):371-80.
PMID: 15774523 abstract
Gordon ES, Gordish-Dressman HA, Hoffman EP (2005).
The genetics of muscle atrophy and growth: The impact and implications of polymorphisms
in animals and humans. Int J Biochem Cell Biol. 37(10):2064-74.
PMID: 15967701 abstract
ES Gordon, EP Hoffman (2001).
The ABC’s of limb-girdle muscular dystrophy: alpha sarcoglycanopathy, Bethlem myopathy,
calpainopathy and more. Current Opinion in Neurology; 14:(5):567-573.
PMID: 11562567 abstract
|
|
|